Circulating CD14+HLA-DR−/low myeloid-derived suppressor cell is an indicator of poor prognosis in patients with ESCC
Crossref DOI link: https://doi.org/10.1007/s13277-015-3426-y
Published Online: 2015-05-14
Published Print: 2015-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Huang, Haitao
Zhang, Guangbo
Li, Guangbin
Ma, Haitao
Zhang, Xueguang
Text and Data Mining valid from 2015-05-14